Rheumatology - Rheumatology Xagena

Rheumatology

News

Drugs

Xagena Medicine

Xagena.net

Pegloticase for chronic gout

Inflammatory diseases associated with increased cardiovascular risk

Patients with rheumatoid arthritis can be successfully re-treated with MabThera after initial treatment fail

Rheumatoid arthritis: recommendations for therapy

Extent of memory B cell repletion may influence the pathophysiology in rheumatoid arthritis

Rheumatoid arthritis: extent of memory B cell repletion seems to be a key factor influencing the pathophysiology

Autoimmune disease: cardiovascular benefits of anti-TNF therapy in rheumatoid arthritis

Knee osteoarthritis: Glucosamine and/or Chondroitin no better than placebo in slowing structural damage

Hypertension-related adverse events with Arcoxia

New therapeutic target in rheumatoid arthritis: B cell depletion with MabThera, an anti-CD20 antibody

Systemic lupus erythematosus: potential biomarkers for psychosis and cerebrovascular disease

Psoriatic arthritis: significant and sustained improvements with Golimumab

Decreased risk of developing rheumatoid arthritis linked to alcohol intake

Treatment of Denosumab reduces the progression of bone erosion

B-cell depletion therapy for patients with refractory systemic lupus erythematosus

Belimumab improves symptoms in 46 percent of systemic lupus erythematosus patients

Exercise has no effect on risk of knee osteoarthritis

Predicting the risk of rheumatoid arthritis for early arthritis patients

Spondylarthritis: the process of ankylosis could become a separate therapeutic target

Low-dose steroids reduce joint damage from rheumatoid arthritis

Inflammatory arthritis: changes in serum fetal DNA levels associated with disease improvement during pregnancy and recurrence postpartum

Efficacy of Glucosamine, Chondroitin sulfate in patients with moderate to severe osteoarthritis knee pain

Rheumatoid arthritis: chronic, severe inflammation linked to increased lymphoma risk

Acupuncture relieves symptoms of fibromyalgia

Rheumatoid arthritis does not increase risk of hearing loss

FDA has approved Rituxan for treatment of moderate-to-severe rheumatoid arthritis

Statins as potential modifiers of rheumatoid arthritis

The impact of smoking and genes on rheumatoid arthritis

Combination therapy, Adalimumab plus Methotrexate, for achieving remission of early rheumatoid arthritis

Valproic acid, a common anti-seizure drug, could be effective for lupus

Next Pages [1] 2 3

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions